Addus HomeCare (NASDAQ:ADUS) CEO Sells $249,071.04 in Stock

26 Feb 2026, 18:31 by Scott Moore · The Cerbat Gem

Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) CEO R Dirk Allison sold 2,364 shares of the stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total transaction of $249,071.04. Following the sale, the chief executive officer directly owned 183,150 shares of the company’s stock, valued at $19,296,684. This represents a 1.27% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

R Dirk Allison also recently made the following trade(s):

On Tuesday, February 24th, R Dirk Allison sold 4,988 shares of Addus HomeCare stock. The shares were sold at an average price of $106.98, for a total transaction of $533,616.24.

Addus HomeCare Stock Down 3.3%

NASDAQ ADUS traded down $3.58 on Thursday, reaching $104.02. The company had a trading volume of 269,378 shares, compared to its average volume of 239,147. The company’s fifty day moving average is $109.57 and its 200-day moving average is $113.08. The firm has a market capitalization of $1.92 billion, a price-to-earnings ratio of 19.97, a price-to-earnings-growth ratio of 1.26 and a beta of 0.91. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.66 and a current ratio of 1.80. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $124.43.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Invesco Ltd. boosted its holdings in shares of Addus HomeCare by 7.1% in the 4th quarter. Invesco Ltd. now owns 416,857 shares of the company’s stock valued at $44,766,000 after buying an additional 27,683 shares during the last quarter. Caitlin John LLC bought a new stake in Addus HomeCare during the fourth quarter worth $183,000. Empowered Funds LLC raised its position in Addus HomeCare by 186.1% during the fourth quarter. Empowered Funds LLC now owns 70,927 shares of the company’s stock worth $7,617,000 after acquiring an additional 46,137 shares in the last quarter. XTX Topco Ltd acquired a new stake in Addus HomeCare in the fourth quarter valued at $432,000. Finally, VARCOV Co. bought a new position in shares of Addus HomeCare in the 4th quarter valued at about $382,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Wall Street Analysts Forecast Growth

ADUS has been the topic of a number of recent research reports. TD Cowen reissued a “buy” rating on shares of Addus HomeCare in a research report on Wednesday, November 5th. Truist Financial set a $135.00 price target on shares of Addus HomeCare and gave the stock a “buy” rating in a research note on Wednesday, January 7th. Wall Street Zen upgraded shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Monday. Stephens cut their price objective on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Wednesday. Finally, Royal Bank Of Canada restated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Addus HomeCare presently has a consensus rating of “Moderate Buy” and a consensus target price of $134.33.

Get Our Latest Stock Analysis on Addus HomeCare

More Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

Positive Sentiment: Q4 earnings/earnings call emphasized continued revenue growth, margin-leverage opportunities and an M&A-driven growth strategy for 2026 — supports longer‑term earnings upside. Addus HomeCare Earnings Call Highlights Growth And Scale
Positive Sentiment: Stephens trimmed its price target from $140 to $135 but kept an “overweight” rating — the new target implies meaningful upside from current levels, indicating analyst confidence in the company’s outlook despite the cut. Stephens price target note
Neutral Sentiment: Addus will participate in the Raymond James Institutional Investors Conference (investor visibility event; typically neutral but can aid liquidity/coverage). Conference participation
Neutral Sentiment: Some published short‑interest data in the feed shows zero shares (data glitch/inconsistent reporting across sources) — treat those specific zero figures with caution. MarketBeat ADUS page
Negative Sentiment: Significant insider selling over Feb. 24–25: CEO R. Dirk Allison sold two blocks (4,988 and 2,364 shares) and multiple senior EVPs sold smaller blocks across the two days — coordinated insider sales can pressure sentiment even if individual sales are routine and pre‑planned. See CEO filing. CEO insider-sale SEC filing
Negative Sentiment: Short interest rose earlier in February (as of Feb. 13 there were ~1.15M shares short, ~6.5% of shares outstanding and ~4.6 days‑to‑cover) — elevated short activity can amplify downward price moves. Short interest data

About Addus HomeCare

(Get Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.